The missing lever in cancer spend: How evidence-based care reduces variability and shapes total cost
Published
1 Min Read
For HR and benefits leaders: How fertility benefit design drives employee outcomes and total spend.
Why medical specialty drugs are outpacing pharmacy spend, and what self-funded employers can do about it.
Fertility benefits are deeply personal, and increasingly important to employees. For HR and benefits leaders, the challenge is designing coverage that not only supports people in reaching their family building goals, but also manages cost in a sustainable, thoughtful way.
Join us as we reframe how benefits leaders think about cancer spend by focusing on the role of evidence-based care in shaping total cost of care.